Such Attractive Yields in High-Grade Munis Are Rare and May Not Last Long
According to this munis expert, the last time munis were this cheap was a brief period in 2023. If you kicked yourself for missing out then, you have a second chance now.


Municipal bond investors may have a rare and compelling opportunity to lock in high yields.
High-grade municipal bond yields, particularly at the long end of the curve, are near their highest levels in over a decade, according to the Bloomberg Municipal Bond Index through May 8.
And the ratio of the tax-equivalent yield on 30-year AAA-rated munis vs U.S. Treasuries is currently sitting just above 90%, according to Bloomberg's Evaluated Pricing Service as of May 8.

Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
That means many muni bonds are practically offering tax exemption at little or no cost to investors.
The Kiplinger Building Wealth program handpicks financial advisers and business owners from around the world to share retirement, estate planning and tax strategies to preserve and grow your wealth. These experts, who never pay for inclusion on the site, include professional wealth managers, fiduciary financial planners, CPAs and lawyers. Most of them have certifications including CFP®, ChFC®, IAR, AIF®, CDFA® and more, and their stellar records can be checked through the SEC or FINRA.
The combination of high outright yields at that ratio to Treasuries doesn’t happen very often — and when it does happen, it typically doesn’t last long.
The perfect storm: What drove munis to these levels
The reasons are technical in nature:
- Increased supply. Tax-exempt muni issuance in the first quarter of 2025 was 23% above the record pace set the previous year, according to Bloomberg through March 31, putting pressure on municipal yields.
- Treasury market volatility. In early April, the combination of high volatility in the Treasury market and moderate bond-to-equity rebalancing pushed rates for high-grade bonds up significantly at the long end of the curve.
Those headwinds have left munis relatively cheap compared to other fixed-income asset classes and have pushed their total yields up to a high-water mark.
However, as we head into summer, the typical seasonal patterns suggest that supply will decrease and demand will rise, driven by coupon and principal reinvestments.
Despite the recent technical pressures, muni credit quality remains intact at high levels. In recent years, state and local governments have applied excess fiscal stimulus wisely, building rainy-day funds and buffers for turbulent conditions.
Moreover, we expect municipal revenue sources to be largely insulated from any direct impact from tariffs.
In short, we’ll soon be entering a traditionally strong period for munis, with the added appeal of exceptionally cheap valuations and solid credit fundamentals.
Long-dated high-grade munis have become especially attractive of late. The chart below highlights the excess tax-equivalent yields that munis are offering vs Treasuries in the long end of the curve.
This differential has grown significantly since the end of last year. Not only are these opportunities rare, but they are also short-lived.
The investment case in brief
Munis are in good position to deliver strong returns this year, with tax-equivalent yields close to 7% on an after-tax basis, and provide a ballast in the event of an economic downturn, according to the Bloomberg Municipal Bond Index yield and Vanguard calculations as of May 8. (The municipal tax-equivalent yield is calculated using a 40.8% tax bracket, which includes a 37% top federal marginal income tax rate and the 3.8% net investment income tax to fund Medicare.)
Looking for expert tips to grow and preserve your wealth? Sign up for Building Wealth, our free, twice-weekly newsletter.
Given the current yields, valuations and technical tailwinds, longer-dated high-grade munis represent a sweet spot in the market.
Conditions are likely to shift in the coming months, so investors may want to consider seizing this investment opportunity before it’s gone. And remember that all investing is subject to risk, including possible loss of principal. (Read another timely take on muni bonds in the article Financial Analyst Sees a Bright Present for Municipal Bond Investors.)
If you’re considering investing in munis, you should be aware that although the income from a municipal bond fund is exempt from federal tax, you may owe taxes on any capital gains realized through the fund’s trading or through your own redemption of shares. For some investors, a portion of the fund’s income may be subject to state and local taxes, as well as to the federal alternative minimum tax.
Also, bond funds are subject to interest rate risk, which is the chance bond prices overall will decline because of rising interest rates, and credit risk, which is the chance a bond issuer will fail to pay interest and principal in a timely manner or that negative perceptions of the issuer’s ability to make such payments will cause the price of that bond to decline.
Related Content
- Remembering Bogle: A New Standard for Municipal Investing
- GOP Eyes Taxes on Municipal Bond Interest: What You Need to Know
- This Boring Retirement Income Source Has Big Tax Benefits
- Five Considerations About Municipal Bonds if Tax Cuts Sunset
Get Kiplinger Today newsletter — free
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.

Paul Malloy is head of municipal investment at Vanguard. Previously, he was head of Vanguard Fixed Income Group, Europe. In that role, Paul managed portfolios that invested in global fixed income assets. He also oversaw Vanguard’s European Credit Research team. Mr. Malloy joined Vanguard in 2005, the Fixed Income Group in 2007 and has held various portfolio management positions in Vanguard’s offices in the United Kingdom and the United States.
-
Want to Avoid High Blood Sugar as You Age? Stay Married
A healthy blood sugar level can help you avoid type 2 diabetes as you age. If you're married, you can thank your spouse for making that a little bit easier.
-
Average Social Security Claiming Age is Trending Higher
Fewer people are claiming Social Security benefits at age 62. Better health and the elimination of the earnings test after 65 have lowered barriers to working longer.
-
My Three-Day Rule for Investing: And If it Applies Now
Stock Market I've seen a lot in my career. Here's what I see now in the stock market.
-
Financial Analyst Sees a Bright Present for Municipal Bond Investors
High-tax-bracket investors have an excellent opportunity to secure low-volatility, high-quality returns at yield levels rarely seen in over a decade.
-
I'm an Insurance Pro: How Not to Get Dumped by Your Insurance Agent
Your insurance agent or broker might show you the door if you do any of these five things. Being a good customer is about more than paying your bill on time.
-
Stock Market Today: Stocks Climb More Walls of Worry
Volatility is back in a normal range, and the trend for the main equity indexes remains positive despite specific and general headwinds.
-
Is It Time to Invest in Europe?
Stock Market Europe is being shaken out of its lethargy, militarily and otherwise, by Donald Trump's changes in U.S. policy. Should investors start buying?
-
Two Estate Planning Issues You Should Never Overlook
This estate planning attorney explains why proper asset titling and beneficiary designations make a big difference when it's time to transfer your wealth.
-
The Four D's That Could Force You to Sell Your Business
Business owners (or their heirs) can be rushed into a sale of their company if they haven't planned for a major change in circumstances — or the four D's.
-
Stock Market Today: Nasdaq Outperforms as Big Tech Rallies
The Dow Jones Industrial Average closed lower for a second day as Amgen and Merck fell.